Singular Genomics Systems Inc (OMIC)
0.4042
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.4006
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Revenue (Quarterly): 1.081M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.081M |
September 30, 2023 | 0.462M |
June 30, 2023 | 0.505M |
Date | Value |
---|---|
March 31, 2023 | 0.863M |
December 31, 2022 | 0.765M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.462M
Minimum
Sep 2023
1.081M
Maximum
Dec 2023
0.7352M
Average
0.765M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
Bruker Corp | 854.50M |
Azenta Inc | 154.32M |
Harvard Bioscience Inc | 28.15M |
Bionano Genomics Inc | 10.72M |
Akoya Biosciences Inc | 26.49M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -23.25M |
Total Expenses (Quarterly) | 26.36M |
EPS Diluted (Quarterly) | -0.31 |
Enterprise Value | -135.16M |
Gross Profit Margin (Quarterly) | -42.28% |
Profit Margin (Quarterly) | -2.15K% |
Earnings Yield | -321.6% |
Normalized Earnings Yield | -321.62 |